SLC31A1 and neoplasm: Cai et al. provided in vitro evidence with [64Cu]CuCl2 that by knocking down CTR-1 in tumors, showing that the uptake of [64Cu]CuCl2 was reduced compared to the control group, along with the suppression of tumor cell proliferation [96].